The application discloses methods of treating mammalian diseases
characterized by abnormal cell mitosis by administering estradiol
derivatives including those comprising colchicine or combretastatin A-4
structural motifs of the general formulae found below in a dosage
sufficient to inhibit cell mitosis. The application discloses novel
compounds used in the methods.